跳至主要内容
临床试验/NCT02569892
NCT02569892已完成不适用

Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration

Stanford University2 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2016年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
19
试验地点
2
主要终点
Change in Macular Drusen Volume

研究概览

简要总结

This is a randomized controlled study of non-damaging photothermal macular grid laser versus sham laser therapy in patients with dry age-related macular degeneration (AMD) and large high-risk drusen. The goal of the study is to determine if this treatment will reduce macular drusen volume and also whether this might improve visual acuity or reduce the risk of conversion to advanced age-related macular degeneration defined as development of choroidal neovascularization or geographic atrophy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Presence of signs of advanced AMD, such as CNV, haemorrhages or macular atrophy based on OCT and fundus autofluorescence photography (FAF).
  • Previous macular laser treatment.
  • Any previous ocular condition that may be associated with a risk of developing macular oedema.
  • Vitreomacular traction determined clinically and /or by OCT, which in the opinion of the investigator, contributes to the macular oedema (associated or causing a detachment of the fovea).
  • Presence of other macular disease such as epiretinal membrane, macular telangiectasia.
  • Important known allergies to sodium fluorescein dye used in angiography.
  • Ocular or periocular infections.
  • Planned intra-ocular surgery within one year.
  • Patient is unavailable for follow-up visits.

结局指标

主要结局

Change in Macular Drusen Volume

时间窗: baseline, 6, 12, and 24 months

Mean change in macular drusen volume as measured on high-resolution spectral domain ocular coherence tomography (SD-OCT)

次要结局

  • Change in Visual Acuity(baseline, 6, 12, and 24 months)
  • Development of Geographic Atrophy (GA) or Choroidal Neovascularization (CNV)(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Steven R. Sanislo

Professor

Stanford University

研究点 (2)

Loading locations...

相似试验